Yarger Wealth Strategies LLC boosted its position in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 14.7% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 31,681 shares of the company’s stock after acquiring an additional 4,054 shares during the quarter. Yarger Wealth Strategies LLC’s holdings in Bath & Body Works were worth $949,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently added to or reduced their stakes in the company. Stonehage Fleming Financial Services Holdings Ltd acquired a new position in Bath & Body Works during the second quarter worth approximately $33,000. SVB Wealth LLC acquired a new position in Bath & Body Works during the first quarter worth approximately $35,000. Geneos Wealth Management Inc. increased its position in Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after buying an additional 801 shares during the period. Parallel Advisors LLC grew its stake in shares of Bath & Body Works by 63.3% in the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock valued at $37,000 after purchasing an additional 481 shares during the last quarter. Finally, Golden State Wealth Management LLC grew its stake in shares of Bath & Body Works by 94.7% in the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company’s stock valued at $40,000 after purchasing an additional 642 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.
Analyst Ratings Changes
Several research analysts have weighed in on BBWI shares. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $26.00 target price on shares of Bath & Body Works in a research note on Monday, October 6th. Morgan Stanley lowered their target price on Bath & Body Works from $19.00 to $18.00 and set an “overweight” rating on the stock in a research note on Friday, September 12th. Wall Street Zen downgraded Bath & Body Works from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Barclays lifted their target price on Bath & Body Works from $30.00 to $32.00 and gave the company an “equal weight” rating in a research note on Friday, August 29th. Finally, Citigroup lowered their target price on Bath & Body Works from $42.00 to $40.00 and set a “buy” rating on the stock in a research note on Tuesday, August 19th. Eleven investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $38.15.
Bath & Body Works Price Performance
Bath & Body Works stock opened at $24.98 on Monday. Bath & Body Works, Inc. has a 1-year low of $24.85 and a 1-year high of $41.87. The company has a market cap of $5.15 billion, a PE ratio of 7.41, a price-to-earnings-growth ratio of 0.86 and a beta of 1.52. The stock’s 50 day moving average price is $28.02 and its 200 day moving average price is $29.25.
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The firm had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.55 billion. During the same period in the previous year, the business earned $0.37 earnings per share. The company’s revenue for the quarter was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, equities research analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.
Bath & Body Works Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $0.80 annualized dividend and a yield of 3.2%. Bath & Body Works’s payout ratio is currently 23.74%.
Bath & Body Works Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Further Reading
- Five stocks we like better than Bath & Body Works
- What Are the FAANG Stocks and Are They Good Investments?
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- 5 Top Rated Dividend Stocks to Consider
- Could Target’s Week of Discounts Come Full Circle for Investors?
- How to Invest in Blue Chip Stocks
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.